NR4A1 and neoplasm: These factors include clinical palpability [11-14], tumor size [11-17], lymphatic or vascular involvement [11-15, 17], tumor grade [11, 14], hormone receptor (HR) status [16, 17], age [12, 15, 16], and molecular subtype classification [3, 10, 18-26].